There were 120 press releases posted in the last 24 hours and 440,198 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Versartis Initiates Phase 3 Trial of Somavaratan in Japan for Children with Growth Hormone Deficiency Following Completion of Phase 2

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image